Neurogene (NGNE)Siren, L.L.C. exited its position 176K shares

176K

Prior-quarter shares · no longer reported

Holdings as of

Dec 31, 2024

Filed

Feb 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

What came next

1. Mar 13, 2025InsiderCFO sold ~$76K of NGNE shares in the open market
2. May 14, 2025InsiderOfficer sold ~$103K of NGNE shares in the open market

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Neurogene

For Neurogene, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NGNE page.

How this filing works

• SEC Form 13F

Other disclosures at Neurogene

• SEC Schedule 13GOct 7, 2026
• SEC Schedule 13GOct 6, 2026
• SEC Form 13F-HRAug 14, 2025
• SEC Form 4May 15, 2025
• SEC Form 4Mar 17, 2025
• SEC Form 13F-HRFeb 14, 2025

Everything OQRO holds on this company is on its NGNE page.